Terawulf (WULF) had the highest return between May 31, 2024 and June 28, 2024 by a mid-cap US stock, returning 92.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Terawulf (WULF) | 5/31/2024 - 6/28/2024 | 92.64% |
Hut 8 Corp Common Stock (HUT) | 5/31/2024 - 6/28/2024 | 65.82% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 5/31/2024 - 6/28/2024 | 59.32% |
Avidity Biosciences (RNA) | 5/31/2024 - 6/28/2024 | 50.68% |
IREN (IREN) | 5/31/2024 - 6/28/2024 | 49.73% |
Sprint Communications (S) | 5/31/2024 - 6/28/2024 | 42.52% |
Mirum Pharmaceuticals (MIRM) | 5/31/2024 - 6/28/2024 | 39.32% |
Applied Digital (APLD) | 5/31/2024 - 6/28/2024 | 38.69% |
Six Flags Entertainment (FUN) | 5/31/2024 - 6/28/2024 | 32.93% |
RXO (RXO) | 5/31/2024 - 6/28/2024 | 31.54% |
Ionis Pharmaceuticals (IONS) | 5/31/2024 - 6/28/2024 | 30.4% |
American Superconductor (AMSC) | 5/31/2024 - 6/28/2024 | 30.09% |
Grindr (GRND) | 5/31/2024 - 6/28/2024 | 29.66% |
Disc Medicine (IRON) | 5/31/2024 - 6/28/2024 | 29.62% |
Nuscale Power (SMR) | 5/31/2024 - 6/28/2024 | 29.03% |
PureCycle Technologies (PCTTW) | 5/31/2024 - 6/28/2024 | 27.42% |
GeneDx (WGS) | 5/31/2024 - 6/28/2024 | 27.39% |
Denali Therapeutics (DNLI) | 5/31/2024 - 6/28/2024 | 27.02% |
Cinemark (CNK) | 5/31/2024 - 6/28/2024 | 26.73% |
Akero Therapeutics (AKRO) | 5/31/2024 - 6/28/2024 | 25.79% |
DXC Technology (DXC) | 5/31/2024 - 6/28/2024 | 25.26% |
Verona Pharma PLC ADR (VRNA) | 5/31/2024 - 6/28/2024 | 25.19% |
Axcelis Technologies (ACLS) | 5/31/2024 - 6/28/2024 | 24.76% |
Life360, Inc Common Stock (LIF) | 5/31/2024 - 6/28/2024 | 24.58% |
Madrigal Pharmaceuticals (MDGL) | 5/31/2024 - 6/28/2024 | 23.81% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
